PF-08046876

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-08046876, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors [Phase 1]